| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/15/1996 | CA2196082A1 Quinoa saponin compositions and methods of use |
| 02/15/1996 | CA2195850A1 Substituted indoles |
| 02/15/1996 | CA2194488A1 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection |
| 02/15/1996 | CA2172830A1 Method for inhibiting nucleoside and nucleobase transport and virus replication in mammalian cells |
| 02/14/1996 | EP0696287A1 Ureido derivatives of naphthalenephosphonic acids and process for their preparation |
| 02/14/1996 | EP0696277A1 Hiv protease inhibitors useful for the treatment of aids |
| 02/14/1996 | EP0696275A1 Vitamin d amide derivatives |
| 02/14/1996 | EP0696204A1 Recombinant fowlpox viruses and uses thereof |
| 02/14/1996 | CN1030999C Process for preparation of trypsin inhibitor |
| 02/13/1996 | US5491231 Hindered N-oxide esters of rapamycin |
| 02/13/1996 | US5491229 Rapamycin derivative |
| 02/13/1996 | US5491166 Inhibitors of HIV protease useful for the treatment of AIDS |
| 02/13/1996 | US5491163 (Thia)cycloalkyl[B]indoles |
| 02/13/1996 | US5491150 Supplementary therpeutic agents for the treatment of immunodeficiency syndrome |
| 02/13/1996 | US5491147 Tri-substituted phenyl derivatives and their use in pharmaceutical compositions and methods of treatment |
| 02/08/1996 | WO1996003501A1 Dual hybrid system |
| 02/08/1996 | WO1996003430A1 Organic compounds |
| 02/08/1996 | WO1996003415A1 Human potassium channel 1 and 2 proteins |
| 02/08/1996 | WO1996003407A1 Compounds useful as antiproliferative agents and garft inhibitors |
| 02/08/1996 | WO1996003399A1 Dihydrobenzofuranes |
| 02/08/1996 | WO1996003396A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 02/08/1996 | WO1996003383A1 INDOLIZINE sPLA2 INHIBITORS |
| 02/08/1996 | WO1996003376A1 1H-INDOLE-1-FUNCTIONAL sPLA2 INHIBITORS |
| 02/08/1996 | WO1996003141A1 Pharmaceutical compositions comprising a chimaeric tnf binding protein |
| 02/08/1996 | WO1996003135A1 Pharmaceutical compositions, mainly vaginal suppository, containing many different active ingredients |
| 02/08/1996 | WO1996003125A1 Carbon monoxide dependent guanylyl cyclase modifiers |
| 02/08/1996 | WO1996003123A1 Methods |
| 02/08/1996 | WO1996003120A1 INDENE sPLA2 INHIBITORS |
| 02/08/1996 | DE4192335C2 New T-cell epitope(s) derived from the TraT protein of E.Coli |
| 02/08/1996 | CA2195665A1 Pharmaceutical compositions comprising a chimaeric tnf binding protein |
| 02/08/1996 | CA2195570A1 Indolizine spla2 inhibitors |
| 02/08/1996 | CA2195569A1 1h-indole-1-functional spla2 inhibitors |
| 02/08/1996 | CA2195432A1 Indene spla2 inhibitors |
| 02/08/1996 | CA2195302A1 Carbon monoxide dependent guanylyl cyclase modifiers |
| 02/07/1996 | EP0695354A1 ANTISENSE-OLIGONUCLEOTIDES FOR THE TREATMENT OF IMMUNOSUPPRESSIVE EFFECTS OF TRANSFORMING GROWTH FACTOR-$g(b) (TGF-$g(b)) |
| 02/07/1996 | EP0695308A1 Novel heterocyclic acyldipeptides, processes for the preparation thereof and pharmaceutical compositions containing the same |
| 02/07/1996 | EP0652943A4 Hematopoietic facilitatory cells and their uses. |
| 02/07/1996 | CN1030915C Method for preparation of benzimidazole derivatives |
| 02/06/1996 | US5489697 Catalytic condensation of ethylbutyryl acetate and phloroglucinol yields 5,7-dihydroxy-4-propylcoumarin which is acetylated at position 8, then reacted with 4,4-dimethoxy-2-methylbutan-2-ol, then treated with acetal and reduced |
| 02/06/1996 | US5489586 Method for treating inflammatory disease in humans |
| 02/06/1996 | US5489441 Method for suppressing immune response associated with psoriasis, contact dermatitis and diabetes mellitus |
| 02/01/1996 | WO1996002555A1 Immunomodulatory oligonucleotides |
| 02/01/1996 | WO1996002545A1 Heterocycle-condensed morphinoid derivatives |
| 02/01/1996 | WO1996002541A1 8-aryl-1,6-naphthyridin-5-ones |
| 02/01/1996 | WO1996002506A1 Quinoline derivatives as leukotriene antagonists |
| 02/01/1996 | WO1996002497A1 Substituted benzamidines, their production and their use as medicaments |
| 02/01/1996 | WO1996002496A1 Novel chemical compound, its preparation and use as a drug |
| 02/01/1996 | WO1996002271A1 Electrically hydrolyzed salines as in vivo microbicides for the treatment of cardiomyopathy and multiple sclerosis |
| 02/01/1996 | WO1996002248A1 Cannabinoid receptor antagonists |
| 02/01/1996 | WO1996002240A2 Use of inhibitors of human s-cd23 |
| 02/01/1996 | WO1996002233A1 Immunological activity of rhamnolipids |
| 02/01/1996 | WO1996002143A1 Compositions and methods for enhanced tumor cell immunity in vivo |
| 02/01/1996 | CA2560114A1 Immunomodulatory oligonucleotides |
| 02/01/1996 | CA2195082A1 Electrically hydrolyzed salines as in vivo microbicides for the treatment of cardiomyopathy and multiple sclerosis |
| 02/01/1996 | CA2194886A1 Novel chemical compound, its preparation and use as a drug |
| 02/01/1996 | CA2194877A1 Heterocycle-condensed morphinoid derivatives |
| 02/01/1996 | CA2194684A1 Cannabinoid receptor antagonists |
| 02/01/1996 | CA2192478A1 Quinoline derivatives as leukotriene antagonists |
| 01/31/1996 | EP0694307A1 Atopic disease remedy |
| 01/31/1996 | EP0694070A1 Recombinant alphavirus vectors |
| 01/31/1996 | EP0694067A1 T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
| 01/31/1996 | EP0693936A1 CLONED $i(LEPTOSPIRA) OUTER MEMBRANE PROTEIN |
| 01/31/1996 | EP0693931A1 Immunogenic cancer proteins and peptides and method of use |
| 01/31/1996 | EP0608353B1 LOW pH AQUEOUS COSMETIC GEL CONTAINING NON-IONIC POLYACRYLAMIDE DERIVATIVES |
| 01/31/1996 | EP0593615B1 Aromatic compounds, compositions containing them and their use in therapy |
| 01/31/1996 | EP0455785B1 Leucocyte elastasis and cathepsin g-blocking peptide |
| 01/31/1996 | CN1115982A Pharmacologically active pyridine derivatives and processes for the preparation thereof |
| 01/30/1996 | US5487891 Human anti-RH(D) monoclonal antibodies reagents and hybridomas and methods of RH typing using anti-RH(D) monoclonal antibodies and reagents |
| 01/30/1996 | CA1338012C Pharmaceutically active amines |
| 01/25/1996 | WO1996001845A1 Growth differentiation factor-11 |
| 01/25/1996 | WO1996001825A1 Heterobicyclic derivatives |
| 01/25/1996 | WO1996001819A1 Heterocyclic tachykinin receptor antagonists |
| 01/25/1996 | WO1996001817A1 Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase |
| 01/25/1996 | WO1996001813A1 CONFORMATIONALLY RIGID BICYCLIC AND ADAMANTANE DERIVATIVES USEFUL AS α2-ADRENERGIC BLOCKING AGENTS |
| 01/25/1996 | WO1996001646A1 Invariant chain compositions useful for treating autoimmune diseases |
| 01/25/1996 | WO1996001645A1 Use of muramyl peptide compounds |
| 01/25/1996 | WO1996001620A1 Method of priming an immune response in a one-day old animal |
| 01/25/1996 | WO1996001561A1 Method of regulating immune function |
| 01/25/1996 | CA2194872A1 Pyridopyrazine derivatives |
| 01/25/1996 | CA2194702A1 Conformationally rigid bicyclic and adamantane derivatives useful as .alpha.2-adrenergic blocking agents |
| 01/25/1996 | CA2194678A1 Use of muramyl peptide compounds |
| 01/25/1996 | CA2194550A1 Invariant chain compositions useful for treating autoimmune diseases |
| 01/25/1996 | CA2188680A1 Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase |
| 01/24/1996 | EP0693489A1 Heterocyclic tachykinin receptor antagonists |
| 01/24/1996 | EP0693079A1 Derivatives of triterpenoid acids and uses thereof |
| 01/24/1996 | EP0693054A1 Cycloalkylhydroxyureas and their use as lipoxygenase inhibitors |
| 01/24/1996 | EP0692969A1 Method of treatment of diseases by deletion of t cells |
| 01/24/1996 | EP0451216B1 Humanized immunoglobulins and their production and use |
| 01/23/1996 | US5486623 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 01/23/1996 | US5486525 Platelet activating factor antagonists: imidazopyridine indoles |
| 01/23/1996 | US5486510 Method and compositions for modulating or control of immune responses in humans |
| 01/23/1996 | CA2154116A1 1-aryl-2-acetamidopentanone derivatives for use as tachykinin receptor antagonists |
| 01/18/1996 | WO1996001429A1 Method of identifying and producing antigen peptides and use thereof as vaccines |
| 01/18/1996 | WO1996001318A1 Immunomodulators |
| 01/18/1996 | WO1996001275A1 O-glycosylated authentic igf-i and truncated variants thereof, a method of preparation thereof and pharmaceutical compositions |
| 01/18/1996 | WO1996001274A1 NEW hIL-4 MUTANT PROTEINS USED AS ANTAGONISTS OR PARTIAL AGONISTS OF HUMAN INTERLEUKIN 4 |
| 01/18/1996 | WO1996001126A1 Multi-stage cascade boosting vaccine |
| 01/18/1996 | WO1996001122A1 Methods for modulating t cell responses by manipulating a common cytokine receptor gamma chain |
| 01/18/1996 | WO1996001116A1 Chicken infectious anemia virus vaccine |
| 01/18/1996 | WO1996001110A2 Anti-hiv triple combination |